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This is an electron micrograph (a picture 
taken by electron microscope) of a circular 
DNA molecule, or plasmid, the key DNA 
element of genetic engineering. Enlarged 
120,000 times in this micrograph, the 
molecule is large enough to contain four to 
five genes. The DNA molecule is 
11250,000th the size of a human 
chromosome, which is not visible to the 
human eye. The human chromosome 
contains about a million genes. 
This cover highlights the work of 
microbiologists like Dr. Anthony Faras here 
at the University. Faras' work in 
recombinant DNA technology has made 
great inroads in the field of genetics and 
could have far-reaching implications in 
curing diseases as well. For a clear and 
candid overview of the technology, 
application, moral and legal implications of 
genetic engineering, please read the story 
beginning on page 1 by science writer 
George Jordan. We're sure you'll find it as 
fascinating and enlightening as we did. 
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Genetic Engineering Ushers in A 
New Age 
Microbiology professor, Dr. Anthony Faras, works with recombinant DNA bacteria under the biosafety hood in the Recombinant DNA 
Laboratory. The hood is a special safety feature which allows the researcher to perform experiments with infectious bacteria in a controlled 
environment that prevents the spread of this bacteria. 
By George E. Jordan 
The journey into the world of genetic 
engineering- the altering of heredity 
by transplanting genes from one 
organism to another- has turned the 
second half of the 20th century into the 
age of the biologist. 
Test-tube babies, the development of 
oil-eating bacteria and methods of 
screening for genetic defects, talk of 
human cloning and "plant people," 
and the actual creation of organisms in 
the laboratory are products of a new 
technology that promises startling 
breakthroughs in the future. 
Experiments with basic recombinant 
DNA technology, or gene splicing, are 
being conducted in laboratories across 
the nation. Scientists' dreams of curing 
hereditary diseases through gene 
transplants and development of better 
biochemical products are on the verge 
of becoming a reality. 
"Restrictions with regard to the 
future of recombinant DNA are limited 
only by the human imagination," said 
Anthony Faras, a professor of 
microbiology engaged in recombinant 
DNA cancer research at the University 
of Minnesota. 
"Any gene of interest, whether for 
scientific or industrial reasons, can be 
isolated, characterized and its gene 
products reproduced by recombinant 
DNA technology," Faras said. 
At the University of Minnesota, 
recombinant DNA technology is being 
applied in 24 research projects. The 
scope of the work is broad, and 
preliminary gene splicing research 
holds promise of yielding cures for 
many diseases. 
University researchers are using the 
technology to study gene structure, to 
search for viral cancer agents and to 
The basic techniques of recombinant DNA technology. 
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compare blood disorders in animals to 
those in humans. Other projects 
include work on improving the 
fermentation of yeast and increasing 
the yield of farm crops. 
Although the science of genetic 
manipulation is in its infancy, it has 
already raised a multitude of issues 
that society must face, issues that will 
force mankind to rephrase questions 
about the meaning of its existence. 
Suppose that scientists could alter 
the properties of any living thing. 
Imagine a society rid of illnesses like 
Huntington's chorea, cystic fibrosis, 
diabetes, sickle cell anemia and 
cancer. In a sense, science and 
technology might be in a position to 
control the genetic destiny of mankind. 
But is it wise to attempt control over 
such destiny? Do the benefits of curing 
heredity diseases outweigh the risk of 
engineered 
E. coli 
Dr. Faras holds a petri dish in which bacteria containing recombinant DNA is isolated. 
encountering some unknown evil? 
"I don't think man will ever be wise 
enough to know what to breed for to 
protect the survival of mankind," said 
Irwin Rubenstein, a University 
professor of genetics and cell biology 
engaged in recombinant DNA research 
with agricultural plants, such as corn. 
Moreover, assuming science cannot 
overcome social and economic 
realities, who will benefit from or be 
able to afford the new cures? "To 
divorce the discovery of recombinant 
DNA from the society surrounding that 
d·1scovery is foolish," Val Woodward, 
University professor of genetics and 
cell biology, said. 
Prior to the landmark Supreme Court 
decision last spring that living matter is 
patentable, most public debate over 
genetics concerned the theories of 
Authur Jensen and William Shockley 
who claim that blacks are genetically 
inferior to whites. 
How would America's Jensens and 
Shockleys like to see gene splicing 
technology used? 
And Pope John Paul II, the spiritual 
leader of 706 million Catholics, warned 
at a conference this fall that dire 
consequences could result if gene 
splicing technology was not guided by 
humanistic principals. 
Advocates of genetic manipulation 
say public clamor over recombinant 
DNA experiments overlooks the 
enormous potential for good. Genetic 
engineering companies, such as 
Genentech of California, they argue, 
have developed such products as 
human insulin, human growth 
hormones and interferon, a type of 
natural virus fighter and potential 
cancer drug. 
Scientists anticipate the 
development of bacteria that will turn 
pollutants into fuel and enrich 
foodstuffs before the turn of the 
century. And it's likely genetic 
engineers will find vaccines effective 
against some forms of cancer. 
Recombinant Gene Splicing 
While moral and ethical arguments on 
both sides of the genetic engineering 
controversy are confusing, the actual 
process of gene splicing is simple to 
understand. 
The term "recombinant" refers to the 
splitting and recombining of genes, the 
substances that govern the machinery 
of the living cell. DNA, or 
deoxyribonucleic acid, is the agent that 
carries the information of heredity in 
discrete units called genes. 
Genes are microscopic, but play an 
enormous role in determining how 
every cell in every living thing develops 
and matures, from the frog in the pond 
to the next Albert Einstein. Human 
beings have roughly 50,000 active 
genes, and each is programmed to 
perform a different function. 
Genes are strung together into 
threadlike bodies called chromosomes, 
which carry the "information" that 
directs the body's physiology from 
womb to death. Think of a 
chromosome as a string of genes 
similar to a necklace of pearls. 
In the 1970s, researchers developed 
"restrictive enzymes" that could 
dismantle chromosomes neatly into 
individual genes. In effect, restrictive 
enzymes act like scissors, cutting the 
string of pearls, and breaking a 
chromosome into individual genes that 
can be isolated and studied. 
Once a chromosome is separated 
into its individual genes, scientists can 
introduce these genes into a bacteria 
host where the genes turn out 
countless copies of themselves. The 
copies, called clones because they are 
identical in every respect to the 
original gene, can be tested for their 
specific functions. 
If researchers identify a gene that 
tells a cell, for instance, to produce a 
specific protein, the gene can then be 
recombined with a plasmid vector, or 
host, and introduced into bacteria, 
inducing the bacteria to manufacture 
the protein. 
In theory, the technique could allow 
scientists to accomplish the genetic 
blend of two altogether different 
creatures incapable of mating by 
inserting the genes from one into the 
chromosomes of the other. 
Cancer cures? 
Since the late 1950s, the American 
scientific community has been on a 
collective quest to find a cure for 
cancer, and while it has thus far 
produced many positive results, a cure 
for some cancers has yet to be found. 
The bulk of the University of 
Minnesota cancer research using 
recombinant DNA technology is 




BACTERIAL IS ISOLATED 
THE DNA AT SPECIFIC SITES AND ALLOWING 
AN ENZYME IS/ ADDED TO THE PLASMID CUTTING 
IT TO OPEN 
DEVELOPING A HEPATITIS 








SAME ENZYME USED TO CUT DNA 
OF INTEREST 
DNA FRAGMENT CONTAINING THE 
VIRAL COAT PROTEIN DNA GENE 
~ 
THE SECOND GENE IS INSERTED INTO 
THE OPENED PLASMID, WHERE IT FITS 
EXACTLY, AND FORMS RECOMBINANT DNA 
) THE RECOMBINANT PLASMID IS INSERTED BACK INTO THE BACTERIUM, WHICH DIVIDES AND REPLICATES, COPYING ITSELF AND THE RECOMBINANT DNA 
~----
EXPRESSION OF HEPATITIS B 
COAT PROTEIN GENE 
COAT PROTEIN USED FOR VACCINE 
A specific application of recombinant DNA technology. 
Dr. Faras directs numerous University research and educational programs that utilize recombinant DNA technology. He also heads the 
well-equipped Recombinant DNA Laboratory at the U, pictured above. The lab has special air, filter, and climatic controls to contain the 
spread of infectious bacteria within the walls of the lab. This physical containment lab was set up over a year ago with assistance from the 
Minnesota Medical Foundation. It provides a safe, controlled environment where Faras and his team of researchers can work without fear of 
dangerous bacteria escaping from the room. 
become cancerous and the role genes 
might play in cancer. 
"Cancer is a very complicated 
disease," Faras said. "At present, we 
have a better basic understanding of 
the nature of cancer-causing genes 
than we did a few years ago." 
Faras' research group is studying 
two aspects of cancer: how normal 
genes "turn on" to cause cancer, and 
why certain benign (noncancerous) 
tumors, such as warts, progress into 
cancer tumors. 
The progress of warts from benign to 
cancerous is rare, occurring only in 
certain types of warts, such as 
anogenital warts and reddish skin 
warts called epidermodysplasia 
verruciformis. 
Faras' group has found that such 
warts are caused by a specific virus, 
called the papilloma virus. Researchers 
speculate that the virus activates a 
gene, or combination of genes, that 
usually lie dormant in normal wart 
tissue. 
Infections and viral diseases are 
commonly fought through the use of 
vaccines. The virus responsible for 
polio, for example, is grown in large 
amounts in the laboratory where it is 
killed and purified. The killed-virus is 
then injected into the body, causing 
the immune system to react against the 
intruder by manufacturing antibodies 
that attack the foreign virus. 
But the problem with the papilloma 
virus is that it cannot be grown in the 
laboratory. How, then, can a vaccine be 
produced? 
The papilloma virus looks like a 
series of sphere-shaped particles, each 
surrounded by a protein shell. The 
shell is foreign to the human body and, 
therefore, signals the immune system 
to attack. 
Faras' research group at the 
University of Minnesota is using 
recombinant DNA technology to 
identify the gene, or combinant of 
genes, in the papilloma virus that 
directs its particles to produce the 
protein shell. 
If such genes are identified, through 
basic gene splicing techniques, they 
can be extracted from the virus' 
genetic information, cloned, and 
introduced into bacteria where they 
would produce the virus protein. 
"We can inject the 
bacteria-produced virus protein into 
the body," where it will trigger the 
immune system to manufacture 
antibodies against the live, infectious 
virus, Faras said. 
"In effect, through recombinant DNA 
technology you could have a vaccine 
being produced in bacteria tissue 
culture," he said. 
If the papilloma virus is shown to 
play a role in cancer, and researchers 
are successful in developing a vaccine, 
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Faras' group has made significant strides in 
recombinant DNA cancer research. 
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it's possible that such a vaccine might 
help reduce the incidence of cancer. 
Faras warns, however, that much 
work must be done before a papilloma 
virus vaccine can be developed. He 
said that experiments are yet to prove 
that a virus is involved in wart-derived 
cancers. 
Legal Questions 
If researchers develop better 
biomedical agents or new vaccines, the 
material would logically be in demand. 
And potentially lucrative patents on 
agents stemming from genetic 
engineering research have investors 
proclaiming the age of gene splicing as 
"The New Industrial Revolution." 
Several universities, including 
Harvard, Yale, the Massachusetts 
Institute of Technology and the 
University of California, hold patents 
on biomedical products developed 
through genetic manipulation. 
Harvard University announced 
recently it was considering the 
establishment of a genetic engineering 
company, but later shelved the idea 
after faculty members said the plan 
could violate standards of academic 
freedom and curtail the common 
practice of sharing research materials. 
Sprouting up in industrial parks 
across the nation are small commercial 
companies seeking ways to 
mass-produce biomedical products, 
such as human growth hormones and 
interferon, a potential cancer drug, 
genetically engineered in the 
laboratory. 
None of the much-heralded products 
of gene splicing have reached the 
market yet, nor is anyone sure how 
effective genetically engineered insulin 
and interferon, the two products 
closest to market, will be. 
But maneuvering by companies to 
capitalize on the molecular genetics 
industry has raised a number of legal 
and scientific issues. Who owns 
microorganisms being produced in 
collaborative efforts between scientists 
and commercial researchers? 
The University of California at Los 
Angeles is engaged in what's expected 
to be a lengthy court battle with 
Hoffmann-LaRoche, Inc. and 
Genentech over an interferon 
producing cell line developed by 
university researchers and eventually 
cloned by Genentech. 
The central issue is whether the 
university has property rights over 
human genes. Legal experts say no 
court has set precedent in such 
matters. 
Scientists are concerned that court 
battles stemming from genetic 
engineering will undermine research 
collaboration. They contend that 
because of the strong incentive to 
make money, publication of research 
findings may be delayed until enough 
information is obtained for a patent 
application. 
Most researchers are less 
pessimistic, saying the flow of research 
fluctuates and that any rift caused by 
gene splicing conflicts is only 
temporary. 
Campus News 
M.D. Raises Funds for Leukemia 
Research at MMF 
Dr. Grant Olson, a 1933 alumnus of the 
U of M Medical School, West Concord, 
Minn., recently helped provide $1,500 
in leukemia research funds for the 
Medical School just by mentioning the 
Minnesota Medical Foundation to a 
patient who asked him for advice. 
Mrs. Aldrich Iverson, whose husband 
had just died of leukemia, asked Dr. 
Olson the best way to direct memorial 
gifts to research. He told her that the 
Minnesota Medical Foundation does 
not deduct operating expenses or 
overhead from gifts and gave her the 
address (Box 193 University Hospitals, 
University of Minnesota, Minneapolis, 
Mn. 55455). She told her friends, and, 
to date, the memorial gifts have 
totalled $1 ,500, enough to fund the 
average start-up research project. 
The Foundation accepts gifts in 
support of its general purposes or 
those restricted to particular research 
or educational interests of 
contributors. Memorial gifts are 
acknowledged promptly to the 
surviving family (not by dollar amount) 
and receipted to the donor. 
MMF Trustee Donates $50,000 for 
Student Loans 
Gladys and Rudolph W. Miller, of 
Winona and Excelsior, Minn., recently 
gave $50,000 to the Minnesota 
Medical Foundation to set up a student 
loan fund for U of M medical students. 
Miller, a prominent Winona 
businessman, was recently elected to 
the Foundation's Board of Trustees. He 
has been a very generous supporter 
and contributor to the Foundation in 
the past. The new student loan fund 
will be entitled "The Gladys and 
Rudolph Miller Loan Fund." 
Name of Masonic Hospital 
Changed 
The U of M's Masonic Hospital has 
been changed to the Masonic Cancer 
Center to reflect its development as a 
cancer research-patient care center. 
Dean Gault To Visit Panama 
U of M Medical School Dean Neal L. 
Gault, Jr., was recently named a United 
States delegate to the VIII 
PanAmerican Conference on Medical 
Education, Panama City, Republic of 
Panama. Gault recently completed six 
years as an elected member, 
representing the Midwest-Great Plains 
medical schools of the Administrative 
Board of the Council of Deans and the 
Executive Council of the Association of 
American Medical Colleges (AAMC). 
Najarian Receives Honorary 
Doctorate 
Dr. JohnS. Najarian, professor and 
chief of surgery at University Hospitals, 
received an honorary doctorate from 
the University of Athens Medical 
School, Nov. 6, 1980. At the award 
ceremony, Najarian presented a lecture 
on "Transplantation for Diabetes 
Mellitus." Host for the social and 
medical program was Dr. Pan 
Chrysospathis, professor and chairman 
of surgery at the University of Athens. 
50-Vr. Class Reunion, June 4, 5 
All members of the U of M graduating 
medical classes of 1930,1931, and 
1932 are invited to attend their 50-Year 
Reunion celebration, June 4 at 6:30 
p.m. at the Town and Country Club. Dr. 
Vernon D. E. Smith, Dr. 0. L. Norman 
Nelson, Dr. S. Lane Arey, Dr. Bror 
Pearson, and Dr. Richard Lindgren are 
planning the events. On June 5, the 
following day, the entire visiting 
reunion party will be honored at the U 
of M Medical School1981 Graduation 
Program at Northrop Auditorium, Dean 
Gault announced. 
For information, contact Kathy 
Broderick, Minnesota Medical 
Foundation, (612) 373-8023. 
U of M Spring Seminar & 
Reunion to Take Place March 27 
The third annual "New Horizons in 
Minnesota Medicine" Spring Seminar 
and Reunion Program will be March 
27, 1981, Dr. James P. Brown, Medical 
Alumni president, announced. 
All University of Minnesota medical 
alumni and their colleagues are invited 
to attend this one-day event sponsored 
by the U of M Medical Alumni Society, 
from 9 a.m. to 3:30p.m. in the Health 
Sciences Unit A building on campus. 
The seminar is a program of 8-10 
information sessions covering a wide 
scope of up-to-date techniques, 
advances, research and issues of 
modern medicine. Noted Medical 
School researchers and faculty 
members will lead these sessions. 
At noon, a special luncheon will 
feature the 44th Annual Meeting of the 
Medical Alumni Society, with 
presentation of the prestigious Harold 
S. Diehl Award to a distinguished 
alumnus. 
AU of M Medical Alumni Reception 
will take place from 6 to 8 p.m. at the U 
of M Alumni Club in the IDS Tower in 
downtown Minneapolis. After the 
reception, numerous activities are 
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Campus News 
planned for medical alumni from the 
classes of 1946, 1951,1956,1961, 1966, 
and 1971. 
The seminar offers participants five 
Continuing Medical Education Credits 
in Category I and five credits from the 
American Academy of Family 
Physicians. 
For further information and 
reservations, call the Minnesota Alumni 
Association at (612) 373-2466. 
Shideman Elected Convention 
President 
Dr. Frederick E. Shideman, chairman 
of the department of pharmacology at 
the University of Minnesota Medical 
School, has been elected president of 
the United States Pharmacopeia! 
Convention (USPC). 
The convention establishes 
standards for drug use in the United 
States, and is composed of delegates 
from each college and state 
association of medicine and pharmacy, 
22 national organizations and eight 
agencies of the federal government. 
Standards approved by the USPC are 
enforced by the federal Food and Drug 
Administration. 
Shideman has been a member of the 
University of Minnesota faculty since 
1962. He holds a doctorate in medicine 
from the University of Michigan and a 
doctorate in pharmacology from the 
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University of Wisconsin. 
A member of many professional and 
honorary societies, Dr. Shideman is 
also chairman of the National Council 
on Drugs. He served for five years as 
chairman of the scientific advisory 
committee on drugs to the U.S. 
Department of Justice. 
Wannamaker Receives 1980 Koch 
Prize & Medal 
this occasion and delivered a lecture, 
which will be published in a scientific 
journal. 
Wannamaker has been a member of 
the faculty of the University of 
Minnesota Medical School since 1952. 
In 1958 he was named a Career 
Investigator of the American Heart 
Association, a life-time appointment 
with possibility of pursuing research 
studies at any university he chooses, 
but he has elected to remain at the 
University of Minnesota. In September, 
1980, Dr. Wannamaker went on 
sabbatical leave, studying and 
continuing his investigations of 
streptococcal infections and their 
complications at the Rockefeller 
University, New York City, under the 
auspices of a Macy Faculty Scholar 
Award. 
Paula Clayton Named Head of 
Psychiatry 
Dr. Paula Clayton, professor of 
psychiatry at Washington University in 
St. Louis, has been named professor 
and head of psychiatry at the University 
of Minnesota Medical School. 
The appointment was approved this 
fall by the University's Board of 
Regents. 
Clayton, 45, is the first woman to 
head a Medical School department at 
the University. She replaces Dr. William 
Hausman, who resigned. 
Clayton holds a bachelor's degree 
from the University of Michigan and an 
M.D. degree from Washington 
University, where she has been a 
School of Medicine faculty member 
since 1961. She has also served as a 
clinical psychiatrist at Barnes and 
Renard Hospitals in St. Louis. 
Among Clayton's professional 
interests is the study of how people 
cope with grief. She has published 
more than 60 professional articles on 
this and other subjects. 
Clayton serves on the editorial 
boards of Biological Psychiatry and the 
Journal of Affective Disorders. 
LaBree Accepts U of M Position 
Dean John W. LaBree has been named 
Assistant Vice President in the Office 
of the Vice President for Health 
Sciences at the University of 
Minnesota, Twin Cities Campus. 
The position was approved May 9 by 
the University of Minnesota Board of 
Regents. 
LaBree will be responsible for 
coordinating all existing health science 
outreach teaching and service 
programs at the University of 
Minnesota, as well as planning new 
outreach efforts. 
Some of the outreach efforts include 
the Area Health Education Consortium 
(AHEC) and all continuing education 
programs, according to LaBree. He will 
continue his interests in teaching and 
patient care through the department of 
medicine at the University of 
Minnesota Medical School. 
LaBree succeeded Robert Carter as 
dean in 1975. As dean, he strengthened 
community physician support, 
acquired funds for faculty research and 
saw an increase in both faculty and 
class size. Also during his tenure, a 
new medical teaching facility was built 
on the UMD campus. 
A cardiologist, LaBree received his 
M.D. from the University of Minnesota 
Medical School in 1940. Before coming 
to UMD, LaBree was Director of 
Medical Education at St. Mary's 
Hospital in Minneapolis from 
1970-1975. He was one of the ten 
original founders of the St. Louis Park 
Medical Center. 
LaBree assumed his new position 
this summer. 
Behavioral Health Clinic Opens at 
U of M 
A behavioral health clinic that can help 
people with smoking, drinking, eating 
and stress problems has opened at 
University of Minnesota Hospitals. 
Staffed by psychologists, social 
workers, psychiatrists and nurses, the 
clinic is open weekdays from 8 a.m. to 
5:30p.m for patient evaluations. 
Treatment sessions are held during the 
evening. 
"Health care providers are beginning 
to recognize that treating a specific 
disease alone is not sufficient," said 
Dorothy Hatsukami, clinic director. "It 
is also important to treat the problem 
behaviors that cause or exacerbate the 
illness. The clinic helps people modify 
or eliminate behavior detrimental to 
their health." 
Following evaluation, a patient is 
assigned to a support group of about 
10 persons with the same problem. The 
group meets once a week for 8 to 10 
weeks to share concerns and learn 
techniques for altering habits. 
"The focus of the program is 
positive," said Juanita Klukken, 
program coordinator. "We don't 
emphasize previous failures. We stress 
encouragement and support. If 
someone smokes 50 cigarettes a day 
and reduces that by five, that's a small 
success and it should be 
commended." 
Although the majority of patients are 
expected to come through referrals 
from health professionals, individuals 
are welcome to contact the clinic 
directly. The program is open to both 
men and women ages 18 and older. 
The clinic is located on the eighth 
floor of the Phillips-Wangensteen 
Building on the Minneapolis campus. 




Metro Council Approves U of M 
Hospitals Project 
A $233-million plan to modernize 
University of Minnesota Hospitals was 
endorsed Dec. 4 by the Metropolitan 
Council, an umbrella planning agency 
for the Twin Cities area. 
In a 7-4 vote, the council 
recommended that State 
Commissioner of Health George 
Petterson grant a certificate of need for 
new construction and renovation of 
hospital facilities on the Minneapolis 
campus. 
A certificate of need is required of 
every licensed hospital in the state 
before any project costing more than 
$150,000 can be undertaken or any 
10 
change is made in hospital services. 
Since 1971, hospital building proposals 
have faced a stringent review process 
aimed at cutting health care costs 
through better use of facilities. 
Approval by the Metropolitan 
Council comes on the heels of a 14-2 
Metropolitan Health Board vote last 
month to back the project. The health 
board's action followed a 
two-and-one-half month review by staff 
and committees. 
Although the University plan drew 
opposition from four Metropolitan 
Council members Dec. 4, none denied 
the apparent need for new facilities at 
--
University Hospitals, portions of which 
were built in 1911. Instead, they 
questioned aspects of the review 
process and financing plan. 
This month the University is 
proposing to the legislature and 
governor a plan to finance the project 
through the sale of state general 
obligation bonds, which will be repaid 
by the University through patient care 
revenue. By borrowing the state's 
"credit card," the University will be 
able to save approximately $40 million 
in debt financing charges. 
Council members voting to endorse 
the project were Todd Lefko of St. 
Paul, Charles Weaver of Anoka, 
Charles Rafferty of St. Pau I, Alton 
Gasper of Minneapolis, Ernest 
Lindstrom of Richfield, Marcia Bennett 
of Columbia Heights and James Daly of 
Belle Plaine. 
Those opposed were Gladys Brooks 
of Minneapolis, Roger Scherer of 
Brooklyn Center, Martin Kellogg of St. 
Paul and Dirk deVires of Minnetonka. 
There were four abstentions. 
Major components of the renewal 
project include: 
• Construction of a new 1 0-story 
building, called Unit J, on the site of 
Powell Hall, the old nursing dormitory. 
Unit J will contain approximately 500 
acute adult and pediatric beds now 
located in the main Mayo hospital 
building and Variety Club Heart 
Hospital. The new facility will also 
contain surgery suites, labor and 
delivery rooms, and diagnostic and 
treatment services. 
• Renovation of Variety Club Heart 
Hospital to house psychiatric services 
now located in Mayo. 
• Renovation of vacated space in the 
Mayo building for administrative and 
support services. 
The certificate of need application 
calls for the licensing of 719 beds-
four more than at present. 
Construction is tentatively scheduled 
to begin in July of 1981. Completion of 
the new facility is scheduled for 1985 
and the renovation should be complete 
in 1987. 
Kelly Elected to AMA Board 
Dr. Robert T. Kelly, a 1952 alumnus of 
the U of M Medical School and a 
clinical associate professor of family 
practice at the U Medical Schools in 
Minneapolis and Duluth, was elected to 
a three-year term on the Board of 
Trustees of the American Medical 
Association (AMA) at the annual 
meeting this summer. He is the first 
trustee to be elected to the board from 
Minnesota since 1940. 
Kelly is a family practice physician in 





at a private clinic composed of a 
nine-man multi-specialty group. 
He has been serving as chairman of 
the American Medical Association's 
Council on Medical Service and was 
added to the 12-man governing body 
by the AMA's 279-member 
policy-making body of the House of 
Delegates. 
A delegate to the American 
Medical Association representing 
Minnesota since 1968, he has been a 
member of the American Medical 
Association's Speaker's Bureau and 
chairman of the Ad Hoc Committee on 
PSRO of the Council on Medical Service. 
Active in the Minnesota Medical 
Association, Dr. Kelly served as 
president from 1971 to 1972. He was a 
member of the House of Delegates of 
the Minnesota Medical Association 
from 1958 to 1972. 
Dr. Kelly's participation in medical 
associations and organizations 
includes member, Minnesota Academy 
of Family Physicians since 1952; 
charter diplomat, American Board of 
Family Practice; and president, North 
Central Medical Conference, 1977-78. 
In addition, he served as chairman of 
the committee which formed the 
Range Medical Society, serving as 
president and secretary-treasurer. 
As a member of the Itasca Memorial 
Hospital in Grand Rapids, Kelly has 
served as president, 
secretary-treasurer, and chairman of 
the Medical Records Committee. 
Ray Anderson Honored at 
Symposium 
The U of M department of pediatrics 
sponsored a two-day symposium on 
pediatric cardiology Oct. 22-23, in 
honor of retiring pediatrics professor, 
Dr. Ray C. Anderson, M.D., Ph.D. 
Anderson had been on the faculty for 
over 31 years. 
The symposium included papers by 
20 former pediatrics residents of the 
University Medical School who had 
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chosen cardiology as an elective. A 
luncheon and special dinner were also 
included in the symposium activities, 
with Dr. Russell Lucas, U of M 
professor of pediatrics, and Dr. Gerald 
Scheibler, professor and chairman of 
pediatrics at the University of Florida, 
officiating. William E. Ladd Professor 
of Cardiovascular Surgery, Dr. Aldo 
Castenada, of Harvard Medical School, 
also delivered a lecture at the 
symposium. 
U of M Seeks Volunteers for 
Ragweed Allergy Study 
Volunteers are needed to participate in 
a University of Minnesota study of 
ragweed allergies. 
Individuals must be 18 years or older, 
residents of the Midwest for at least 
half of their lifetimes, and suffer from 
asthma or hay fever during the 
ragweed season, August and 
September. 
"We are studying the genetics of 
allergic diseases- how they are 
passed on from generation to 
generation," said Dr. Malcolm 
Blumenthal, associate professor of 
medicine and the project director. 
Volunteers will be asked to spend 
two or three hours in the laboratory, 
giving their medical history and 
undergoing some simple skin and 
blood tests. The project needs 100 
ragweed-sensitive individuals. 
Persons interested in participating in 
the study may contact the University of 
Minnesota Allergy Research Laboratory 
at 373-4328. 
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Eivind Hoff, executive director of the Minnesota Medical Foundation, presented Joseph 
Prohaska, UMD assistant professor of biochemistry, with a $25,000 check this summer for 
purchase of an atomic absorption spectrophotometer, to be housed in the biochemistry 
department at the University of Minnesota-Duluth. 
The AAS unit is equipped with graphite furnace capabilities to enable researchers to 
analyze trace amounts of elements present in biological samples. Prohaska, for example, will 
use it to measure copper levels in small amounts of brain tissue. As little as 5X10·' grams of 
copper can be detected with this instrument. 
Pictured from left to right are former Dean John LaBree, Paul Anderson, chairman of the 
biochemistry department, Prohaska, Hoff, and Dr. Robert Howard, former trustee of the 
Minnesota Medical Foundation. 
Flynn Wins Ernst Award 
Dr. Kevin Flynn, St. Paul, recently 
won the 1980 Kenneth F. Ernst Award, 
a $300 prize and plaque for 
outstanding research in anatomic 
pathology sponsored by the Minnesota 
Medical Foundation. He recently 
completed a residency in pathology 
and has just begun a residency in 
dermatology at the University of 
Minnesota. 
Flynn won the award for his research 
in pathology on "Regressing Atypical 
Histiocytosis." In his research, he 
combined his pathology and 
dermatology interests to define and 
name a very unusual skin tumor, 
Regressing Atypical Hystiocytosis 
(RAH). RAH is a condition that is 
treated as a malignancy based upon its 
appearance under the microscope. But 
Flynn has found that RAH is probably a 
"far more indolent disease than 
ordinarily expected." "This research 
may help patients with this condition 
avoid radical treatment usually 
prescribed for malignancies," Flynn 
said. 
Over 300 Parents of Med Students 
Come to Learn about Med School 
• 
~ 
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Parents get a glimpse of the Medical Bulletin at Parents Day. 
More than 300 persons attended the 
annual Parents Day, Nov. 1, sponsored 
by the Minnesota Medical Foundation. 
Parents of first-year med students 
came from as far away as California, 
and as close by as the twin cities and 
many of the surrounding suburbs and 
counties. 
Begun in fall, 1976, Parents Day has 
become an important tradition at the 
Medical School. It's the only time that 
parents and their children can learn 
together about the Medical School 
experience and share in each others' 
observations and concerns. It's a time 
to relax, talk, reflect, and relate to each 
other. And it's a good break for 
students from the rigors of medical 
classes. 
The day consists of a variety of 
structured and informal activities, 
including guided tours of the medical 
and research facilities by faculty and 
students, talks by the deans and by a 
current medical student, and a lunch 
and social hour. 
This year's Parents Day was 
highlighted with talks by Medical 
School deans Dr. Gault, Dr. Sullivan, 
and Dr. McCollister, by Committee 
President, Gale Matson, by first-year 
medical student, Brad Brainard, and by 
Medical Student Council President, 
Ted Grant. The day concluded with 
some encouraging words by associate 
dean Dr. Pearl Rosenberg, who spoke 
on "The Care and Feeding of Medical 
Students.'' 
The event is sponsored and financed 
by a grant from the Minnesota Medical 
Foundation with the assistance of the 
Medical Student Council. 
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Boulger Takes Over at UMD Med 
School 
A plaque on the wall of Jim Boulger's 
office is engraved with his own words: 
"It'll all work out." And for Boulger, 
acting dean at the University of 
Minnesota-Duluth School of Medicine, 
it seems like it has. 
Boulger was appointed acting dean 
July 1, 1980, following the appointment 
of former Dean John W. LaBree as 
Assistant Vice President for Health 
Sciences on the Twin Cities campus. 
While serving as acting dean, Boulger 
is also associate dean for 
administration, admissions and student 
affairs, and associate professor of 
behavioral sciences and clinical 
sciences. 
The "It'll All Work Out" advice has 
been Boulger's trademark ever since 
March, 1974, when he and his family 
came to the UMD School of Medicine 
from the Medical College of Ohio in 
Toledo. Since that time, he has seen it 
all work out for nearly 200 students 
who have completed their first two 
years of training in the nation's 
northernmost medical school. 
Ninety-six students are currently 
enrolled; 48 in each class. 
It has all worked out, too, for the 
Duluth Medical School. From its 
inception a decade ago, the School 
has attempted to increase the number 
of students entering family practice. 
"To date, an unheard of 58% of our 
students have chosen family practice 
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as a specialty," Boulger said proudly. 
One of the reasons for this success 
is the Family Practice Preceptorship 
Program, which Boulger has directed 
since 1975. 
The program places irldividual 
students with family physicians in 
office and hospital settings throughout 
Northern Minnesota and Wisconsin. By 
providing continuous reinforcement to 
the student who is interested in family 
practice, the preceptorship program is 
extremely popular with both the 
community physicians and students, 
according to Boulger. During their 
preceptor experiences, most second 
year students live with the preceptor 
and his/her family for three, three-day 
periods. 
This year, Boulger was faced with a 
unique problem- more volunteer 
preceptors in small communities than 
second year students! "This should 
serve to strengthen the program, as it 
will enable a few of the physicians who 
have volunteered their time, family and 
community facilities to take a year off 
occasionally," Boulger said. 
Boulger also credits the faculty for 
the medical school's success. They 
have created innovative and productive 
research projects while carrying on an 
excellent teaching program. 
"Over five million dollars in 
non-University funds have been 
obtained over the past eight years to 
support these research and training 
efforts. This does not count such 
important and integral support as the 
Family Practice Financial Aid Fund 
administered by the Minnesota Medical 
Foundation," he said. 
However, the School of Medicine's 
greatest strength lies in people, 
according to Boulger. 
"The medical community- which 
was largely responsible for the 
establishment of the School-
continues to provide us with its fullest 
support. The faculty is dynamic and 
really cares about the School; the 
support staff is superb. The students 
are excellent and really keep us on our 
toes. Support from Vice President 
French, Dean Gault and countless 
others in the Twin Cities has been 
constant and of tremendous help. And, 
Bob Carter and John LaBree provided 
the leadership we needed in the 
start-up and growth stages, 
respectively." 
"The MMF, too, has been superb in 
times of need. One of the recurrent 
problems that every medical school 
faces is financial- there is never 
enough money to fully support all the 
faculty and student programs," he 
said. 
Boulger is also active in the Duluth 
community. Parents of two sons, Jim 
and Peter, Boulger and his wife, Dee, 
serve on the board of the Arrowhead 
Chapter of the Muscular Dystrophy 
Association where Jim is First 
Vice-President. He also is Vice 
President of his church's Parish 
Council, and Dee serves on that 
group's Education Committee. 
As well, Boulger is vice-chairman of 
the Executive Committee of the Duluth 
Graduate Medical Education Council, 
Inc., the parent organization of the 
family practice residency in Duluth, 
and chairman-elect of the Central 
Region of the Association of American 
Medical Colleges Group on Medical 
Education. 
Because of all his responsibilities, 
Boulger is grateful for the help and 
support of family and colleagues. 
"Without the support of my family, I 
just couldn't handle this chaos. And, I 
really am lucky to be at the School of 
Medicine. I don't know of another 
institution where any dean could so 
automatically rely on the excellent 
support of faculty, staff and students." 
And besides, it'll all work out. 
Top-Ranking U Transplant Team 
Brings Hope to Many 
/ -
U doctors perform a kidney transplant. 
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Dr. John Najarian walks out of OR with the 
kidney that he has just removed from the 
donor. 
"I really am lucky. I should have been 
dead a couple of times," said Leon 
Hinnencamp, kidney transplant 
recipient. 
Hinnencamp is not alone. Scores of 
other patients- men, women, 
children, and infants- have received a 
"second chance to live," through the 
efforts of doctors and medical staff at 
the University of Minnesota, 
recognized as the world's leading 
kidney and other organ transplant 
center. 
Unfortunately, like most Americans, 
some physicians living far away from 
transplant centers, consider all 
transplants to be experimental and fail 
to recommend transplant surgery to 
patients who can benefit from this 
procedure. U of M doctors estimate 
that hundreds of patients die each year 
because their physicians are not 
well-informed about the potential of 
16 
transplants. 
Hopefully, the recent flood of 
publicity about the University's organ 
transplant center will encourage 
physicians to seek transplants as a 
cure for their patients, For young and 
middle-aged sufferers of terminal renal 
disease, a kidney transplant is the only 
"cure," according to University 
Hospitals' chief of surgery Dr. John 
Najarian, whose surgical unit does 
more kidney transplants than any other 
in the world. U Hospitals' statistics 
show the "cure" has a 90 percent 
chance of being permanent for 
patients who receive kidneys from 
relatives. 
Far beyond being in the 
experimental stages, kidney 
transplants have become routine at the 
University of Minnesota. Led by 
Najarian the U transplant team has 
perfected kidney transplantation into a 
highly sophisticated and successful 
procedure performed routinely at 
University Hospitals. Today, it's an 
everyday operation. Approximately 160 
kidney transplants are performed each 
year. 
Although kidney transplants have 
become routine, and University 
transplant staff are not as excited 
about the procedure as they used to 
be, they are excited about the high 
success rate- 9 out of 10 patients 
accept new kidneys. 
The surgical technique for kidney 
transplantation dates back to 1902, but 
over the past 78 years, physicians have 
been developing methods to suppress 
the immune system of the body so that 
the transplant is not rejected. 
According to kidney transplant 
surgeon Dr. Ronald Ferguson, "The 
ultimate goal is to fool the immune 
system into thinking the graft belongs 
to the patient." Much progress has 
been made in this area. University 
medical teams use a combination of 
surgery, dialysis, and drugs to 
suppress the immune system and 
increase the body's acceptance of the 
new organ. 
Najarian attributes the increased 
success rate in kidney transplants in 
part to the immunological research 
done at the University and the "new 
surgeons" on the transplant team: Dr. 
Ronald Ferguson, Dr. Richard 
Simmons, Dr. David Sutherland, Dr. 
William Payne, and Najarian, who 
spend as much time in the laboratory 
as in the operating room. "We're better 
today because of the lab work, not the 
surgery," says Najarian. 
Ferguson says that a change in 
attitudes also accounts for the success 
-physicians are much more selective 
and patient about choosing the most 
perfectly matched transplant as 
possible. 
Najarian cites several other factors 
for the increased success. They 
include great advances in immunology, 
discovery of new immunosuppressants 
like Cyclosporin-A, and more effective 
and efficient techniques in 
organ-matching, tissue-typing and 
patient monitoring. 
But, despite the advances in 
transplant technology, doctors and 
researchers are still grappling with the 
problem of manipulating the body's 
tendency to fight off things foreign like 
bacteria, viruses, and new organs. 
"Although we can fool the immune 
system of mice into thinking the graft 
belongs to the patient, our knowledge 
of mice is 15 years ahead of our 
knowledge of people," says Ferguson. 
So the struggle is far from over. 
Especially at the U of M transplant 
center, which concentrates on kidneys, 
implanting more than 150 per year-
one-tenth of the U.S. total. But 
recently, surgeons and staff members 
at University Hospitals have expanded 
their work to include more heart, 
pancreas, and liver transplants. 
The University of Minnesota is a 
locus of transplant activity. It begins 
with the department of surgery on the 
11th floor, which Najarian made into 
the transplant center of the world, and 
spreads out to cover eight floors of 
transplant wards, labs, offices, and 
operating rooms. Activities include 
screening, testing, intensive care, 
treatment, surgery, post-op care of 
transplant patients as well as 
numerous pockets of immunological 
research projects made up of scientists, 
technicians and physicians producing 
immunosuppressant drugs and 
exploring new avenues to find the 
substances, techniques or 
technologies to offset the human 
body's rejection of transplant organs. 
The support staff of other doctors, 
nurses, technicians and administrators 
needed to coordinate the 
medical/surgical/donor responsibilities 
is immense. Cost of transplant patients 
at the University is estimated roughly at 
$5 million a year. And an inestimable 
amount of money goes into the 
research which not only sheds light on 
transplant problems but might provide 
valuable information on other areas-
cancer, arthritis, and other "immune" 
diseases. 
For transplant recipients like Leon 
Hinnencamp, who got a new kidney, 
James Feehan, who has a new heart, 
Larry Gillingham, who has received a 
new kidney and new pancreas, and 
many more successful transplant 
recipients ranging in age from infancy 
through middle age who have suffered 
from chronic heart, kidney, or diabetic 
problems, transplantation has given 
them something priceless- "a normal 
life." 
The U transplant team from bottom left: Dr. 
Richard Simmons, Dr. Ronald Ferguson, Dr. 
John Najarian, Dr. David Sutherland, and 
Dr. William Payne. Photo by Minneapolis 
Star. 
The removed kidney is being profused in preparation for transplantation. 
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UPDATE ON HEART & 
PANCREAS TRANSPLANTS 
Surgeons at the University performed 
the fifth heart transplant operation in 
the history of the institution this past 
October. It was the second transplant 
here in three months. 
Charles Seleskie, 49, of Hastings, 
Minn., received the heart of a 
41-year-old woman in a six-hour 
operation. The heart transplant team 
included Dr. Robert Anderson, Dr. 
Ernesto Molina, and Dr. Ronald 
Ferguson. 
The University's fourth heart 
transplant was performed July 9, 1980. 
Recipient James Feehan is doing well, 
as is the only other survivor among the 
first four transplants, Suzanne Huff, 36, 
who received her transplant in July, 
1978. 
Chief of surgery at the University 
Hospitals Dr. John Najarian said that 
he "anticipates the U of M will 
eventually be designated a heart 
transplant center." 
While Seleskie received the donor's 
heart, patient Larry Gillingham 
received the donor's pancreas in a 
transplant operation performed at the 
University this fall. A 34-year-old 
fireman from Elkhard, Ind., Gillingham 
was suffering from pancreatic failure 
due to diabetes. He is only the 29th 
recipient of a pancreas transplant at U 
Hospitals. Only about 120 have been 
done in the world. The transplant was 
performed by Dr. Najarian and Dr. 
David Sutherland. Gillingham had 
received a kidney transplant at the U 
four years ago. Doctors report his 
kidney and pancreas are both 
functioning well. 
Also this fall, surgeons at the 
University transplanted half a pancreas 
from a woman to her diabetic twin 
sister. It is the first such surgery in the 
world involving identical twins. Dr. 
Najarian reported that the 26-year-old 
woman who received the pancreas 
graft "was doing fine" after the 
operation and may be cured of her 
18 
Diabetic Judith Dent, 26, (right) received 
half of a pancreas from her twin sister, Joan 
McDonald in an operation performed this 
fall at the U. Photo by Dr. David Sutherland, 
one of the transplant surgeons who 
performed this operation. 
"I've never felt better," said Larry 
Gillingham, 34-year-old pancreas transplant 
recipient, who was already riding the 
exercise bicycle a week after his transplant. 
diabetes as a result of the operation. 
The transplant surgery involved 
taking half the pancreas from Joan 
McDonald of Pueblo, Colo., and 
transplanting it into her twin sister, 
Judith Dent, also of Pueblo, who has 
been diabetic since she was four years 
old. The body needs only half a 
pancreas to produce the necessary 
amount of insulin. 
The operation was performed by Dr. 
Najarian and Dr. Sutherland. It was 
only the fourth pancreas transplant 
involving a living donor. The 
transplanted pancreas is functioning 
normally. 
Doctors say the recipient does not 
face the problem of organ rejection 
with part of the normal pancreas from 
a genetically identical sibling. 
Najarian said that chances that 
McDonald will become diabetic are 
practically nil. Studies have shown that 
if the normal twin does not become 
diabetic within five years of the 
diabetic sibling, there is a 95 percent 
chance that she never will. If she 
doesn't become diabetic within 10 
years, there's a 98 percent chance that 
she will not suffer from the disease. 
Dent was suffering from early signs 
of retinopathy. The transplant should 
reverse this trend completely, "We 
hope to have cured her diabetes," 
Najarian said. 
Pancreas transplants are even less 
common than heart transplants. Over 
400 heart transplants have been 
performed in the world, compared to 
only 120 pancreas transplants. 
U of M surgeons performed 14 whole 
pancreas transplants between 1966 
and 1973, then began a program of 
transplanting only the pancreatic islet 
cells, which produce insulin. 
A new series of segmental pancreas 
grafts began in 1978. Dent's surgery 
was the 16th transplant in this series. 
Sutherland said he believes in a few 
years transplants will be accepted as 
treatment for a fairly large number of 
people who become diabetic when 
they are juveniles. It is estimated that 
10,000 new cases of juvenile-onset 
diabetes occur each year in the United 
States. Ten million Americans suffer 
from diabetes, and the incidence of the 
disease is increasing 6 percent a year, 
according to the American Diabetes 
Association. 
Sutherland said that about a fourth 
of juvenile diabetes develop serious 
complications such as eye problems 
leading to blindness, kidney failure and 
loss of sensation due to nervous 
system difficulties. If doctors could 
identify the patients who will develop 
serious complications, they hopefully 
could prevent them with pancreas 
transplantation. 
FAMILY COOPERATION 
COULD EASE SHORTAGE 
OF TRANSPLANT ORGANS 
Thousands of them die every year in 
accidents. They are mostly young, 
healthy people between the ages of 15 
and 25. They are also the ideal 
suppliers of the "gift of life"- organs 
and other body parts suitable for 
transplantation. 
Permission to use the organs of an 
accident victim for transplantation 
must come from the family. Jane Van 
Hook, coordinator of the University of 
Minnesota Organ Donor Program, 
counsels the family on the transplant 
procedure and how the organs will be 
used. 
"Of course this is a hard time for the 
family to make a decision about 
donation," Van Hook said. "Signing 
the permission papers is a very final 
thing. It is probably the family's first 
acceptance that the person is dead. 
For many families it will be the first 
time they have cried." 
Until the family makes a decision, the 
potential donor is kept breathing and 
his blood circulating by artificial life 
support. "These people don't look 
dead," Van Hook said. "Their color is 
still good. The family can see their 
chests are still moving, even though 
the oxygen is coming from a machine." 
Under these circumstances, it is hard 
to accept death, Van Hook said. 
Kidneys are the organs in greatest 
demand, but hearts, livers, eyes, bones, 
and skin for burn victims are also 
needed. "More than half the families I 
talk to will give everything," Van Hook 
said. 
Many people can't separate their 
attachment to the person who has died 
from the body, Van Hook said. They 
still identify the body as the person. 
But even families who are not very 
receptive to the idea of organ donation 
usually give at least one organ when 
asked- generally the kidneys, livers, 
or eyes. "People are more willing to 
donate kidneys and livers because they 
don't associate any emotional or 
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year only 4,000 kidneys were available. 
Jeanette Kircher donated her pancreas to her daughter Joi in June, 1978. The photo of this 
happy pair was taken by transplant surgeon Dr. David Sutherland in August, 1980. 
Most transplants are very successful, 
Van Hook said. The success rate for 
kidneys is 80 percent, for eyes, 95 
percent. Eyes can be kept in culture for 
up to three weeks and skin can be 
freeze-dried. Hearts, pancreases and 
livers must be transplanted 
immediately. Kidneys can be preserved 
for 48 hours. 
Many people are not even aware of 
the need for organs, Van Hook said. "I 
have had people ask 'What for?' when 
I have asked for donations." 
personal attributes with them. The eyes 
and heart are often considered too 
important a part of the person's 
personality and soul," Van Hook said. 
Van Hook does not try to convince 
the family to donate their relative's 
organs, nor does she discuss the 
recipient "although sometimes I do so 
the family knows there is a need for the 
organ," she said. The family of a young 
man who died recently agreed to 
donate a kidney only after Van Hook 
told them a 13-year-old girl was waiting 
for a transplant. "He would have been 
a good donor for heart, eyes, liver and 
bones," Van Hook said. 
Often the families object to donation 
because they don't want the person 
kept on life support for too long, Van 
Hook said. The time between death 
and the transplant must be as short as 
possible. Once the respiratory system 
begins to degenerate, the organs 
deteriorate quickly, Van Hook said. 
Surgery is usually done within 12 hours 
after the family grants permission. 
Once blood samples and tissue 
cultures are taken and a matching 
recipient is found, the donor is taken to 
surgery. For liver, heart and pancreas 
transplants, the recipient's and the 
donor's organs are removed 
simultaneously in adjacent operating 
rooms so the organ can be 
transplanted immediately. The donor is 
removed from life support when 
surgery is completed. 
"We try to keep the donor on life 
support for no longer than 24 hours," 
Van Hook said. "The body is very 
fragile at this point. We have lost 
20 
donors during the ambulance ride from 
another hospital to the University." 
"There is a serious shortage of 
organs," Van Hook said. "We can't 
transplant them fast enough." There 
are 35,000 kidney patients on dialysis 
in the United States. Half of them are 
good candidates for transplants. Last 
Allowing donation can be a very 
positive decision for the victim's family, 
Van Hook said. "I look at my job as 
giving the donor's family the chance to 
pull something positive out of a stupid, 
needless death." 
Kidney and pancreas transplant recipients Mary Ellen Baran and AI Beckler enjoy their new 
lives. Baran received a kidney in 1972 and a pancreas in 1978. Beckler got his kidney in 1974 
and a pancreas in 1979. The photo, taken by Dr. Sutherland, was shot in July, 1980. 
U OF M COMPLETES 
SUCCESSFUL STUDY OF 
NEW ANTI-REJECTION 
DRUG 
A promising new drug in the fight 
against organ rejection in transplant 
patients has been used successfully at 
the University of Minnesota. 
Dr. John Najarian, chief of surgery at 
University Hospitals, announced that a 
six-month experimental study has 
shown "excellent results" in 12 kidney 
transplants. 
Rejection is the body's reaction 
against invading organisms and is 
triggered in transplant operations by 
introduction of the alien organ. 
Massive doses of drugs to suppress 
the immune response are used to fight 
graft rejection, but the drugs also 
lower the body's resistance to 
infection. 
In the University study, 12 adults 
received doses of the new drug, called 
cyclosporin A, following their kidney 
transplants. All 12 patients were given 
cadaver kidneys. Experience has 
shown that these patients are more 
likely to suffer organ rejection than 
patients who receive organs from 
relatives. 
"There were no lost grafts 
(transplanted kidneys). There were no 
serious complications. There was no 
suppression of the white blood cell 
count," Najarian said of the patients in 
the drug experiment. 
Cyclosporin A is the first new 
immunosuppressant drug in 20 years, 
Najarian said. An extract from a 
fungus, the drug was first isolated by a 
Swiss pharmaceutical company 
(Sandoz) from soil. The company was 
routinely mass-screening soil for useful 
antibiotics at the time of the discovery. 
University of Minnesota Hospitals is 
one of only a few institutions in the 
United States authorized to use the 
drug on an experimental basis, 
Najarian said. 
"We are extremely optimistic with 
the early results," he said. "We will 
A closeup of a kidney transplant in progress. 
now start a random study and should 
have some clear-cut answers in two or 
three years." 
Among the "unknowns" are what the 
long-term side effects of the drug 
might be. But in light of the promising 
results to date, Najarian said he is 
confident cyclosporin A will eventually 
be used routinely in the Hospitals' 
transplant program. University of 
Minnesota surgeons now perform 160 
kidney transplants a year. Heart, liver 
and pancreas transplants are also 
performed. 
Mrs. Eleanor Crawford of Denver, 
Colo., was the twelfth and final patient 
to receive the new drug in the 
University study. She was discharged 
from University Hospitals "feeling great 
and having high hopes for the future," 
she said. 
"I was ready to go for anything," said 
Crawford, who suffered from nephritis 
(inflammation of the kidney). "I didn't 
have anything to lose. I was tied up to 




THE INSULIN PUMP 
Making medical history, U of M doctors 
implanted an artificial pancreas, called 
"the insulin pump," in a 56-year-old 
man with diabetes, September 25, 
1980. This is the world's first implanted 
insulin pump, an experimental device 
that should free him of the daily ritual 
of insulin shots, said U of M doctors. 
The pump is about the size of a 
hockey puck, functions like an artificial 
pancreas to deliver the steady flow of 
insulin to the blood-stream. By 
maintaining the body's insulin level 
more steadily than can be achieved by 
daily shots, the pump should help 
minimize eye, kidney, and blood vessel 
damage that often complicates severe 
diabetes, said Dr. Henry Buchwald, 
head of the team that developed the 
device. 
"This is the first patient in the world 
to have an implanted insulin-delivery 
system, although some external units 
have been used," said Buchwald, aU 
of M professor of surgery and 
biomedical engineering. 
Buchwald's patient, a tool-and-die 
maker who asked not to be named, had 
the pump implanted under the skin 
below his left collarbone in a one-hour 
operation. 
Buchwald was joined in the work by 
Dr. Richard Varco, professor of 
surgery, Frank Dorman and Perry L. 
Blackshear, Jr., of the U's Mechanical 
Engineering Department, and Dr. Perry 
Blackshear, who began work on the 
pump at U Hospitals a decade ago and 
now is in Boston. 
The pump consists of two chambers, 
one of which holds the insulin while 
the other holds a compressable 
fluorocarbon gas. Once every two 
weeks, the drug reservoir is filled with 
The implantable infusion pump already in use. Photo by Tom Foley. 
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about 1.3 ounces of insulin solution 
using a syringe inserted through the 
skin. The injection of the insulin 
compresses the fluorocarbon into a 
liquid, and its gradual expansion over 
the next 12-14 days drives the insulin 
through a narrow nozzle into a tube 
leading to the heart. There are no 
batteries and the driving force lasts 
forever. 
"What we plan to do now is watch 
this patient and then, within the next 
year or so, launch a trial at the 
University of Minnesota with 10 to 25 
patients," Buchwald said. He said that 
during this time other institutions will 
be starting similar programs with the 
same device. "I would think that within 
a year or so we will have enough data 
to put the matter before the FDA for 
general market clearance," he said. 
Alumni Notes 
1920s & 1930s 
Fritz D. Hurd, 24, has lived in 
Great Falls, Montana 38 years 
and retired in 1977. He was an 
otolaryngologist until his 
retirement. He writes that he 
spends his time bicycling and 
keeping in good physical 
condition. His daughter is an 
R.N. in the Columbus Hospital, 
Great Falls, and his son works 
for a pharmaceutical company. 
Rodney F. Sturley, '37, St. 
Croix Falls, Wi., retired July, 
1979 from his ob/gyn practice. 
He underwent open heart 
surgery in 1975, receiving a 
triple bypass. He moved to 
Hobby Farm, containing 20 
acres with "lots of grass to 
mow and a big garden." He 
was formerly an assistant 
clinical professor, 
obstetrics/gynecology 
department, University of 
Minnesota and was a physician 
with the St. Paul Women's 
Clinic for 37 years. He lists his 
interests as "taking care of his 
20-acre farm, golf, downhill and 
cross-country skiing." 
1940s 
Howard A. Andersen, '42, a 
specialist in thoracic diseases 
at the Mayo Clinic, received the 
American College of Chest 
Physicians' Distinguished 
Fellow Award at the ACCEP's 
46th Annual Scientific 
Assembly this month. 
Roy W. Dickman, '45, Edina, 
Minn., chief of surgery at 
Methodist Hospital, St. Louis 
Park, Minn. is also an assistant 
professor in the Department of 
Family Practice at the 
University of Minnesota. He 
was given the "Teacher of the 
Year Award by the Methodist 
Hospital/University Family 
Practice group. His major field 
is general, thoracic, vascular 
surgery. His special interests 
include teaching, hunting, and 
touring the U.S. in a 
motorhome. He and his wife 
Patricia have three daughters, 
Pamela, Deborah, and 
Maureen. 
Raymond G. Rowberg, '46, is 
director of medical education 
at Sacred Heart Medical 
Center, Spokane, Wash. He 
writes that he was awarded the 
Wildefeast Tail from the Masai 
tribe in Tanzania as a reward 
for starting a "Barefoot Doctors 
School." He is an internist with 
special interest in geriatics and 
tropical medicine. He has six 
children; three sons in 
medicine at Milwaukee, Wis., 
and one is a teacher in a junior 
college in Tanzania. 
1950s 
Mitchell J. Rosenholtz, '56, a 
pathologist, was appointed a 
full professor at the University 
of Missouri Columbia Medical 
Center. He is also active as the 
chairman of the Boone County 
Common Cause. 
1960s 
Larry R. Erickson, '63, is a 
dermatologist practicing in 
Lakewood and Evergreen Colo. 
He spends his time playing 
racketball, skiing, 
long-distance running- 1 OK to 
Marathon distances. He ran the 
Mt. Evans Trophy run in July 
1980 and the Denver Marathon 
in October, 1980. He and his 
wife Valerie have four children: 
Melanie, 16; Tim, 13; John, 10; 
and Lisa, 8. 
Clarence E. Henke, '63, LTC, 
MC, US Army, graduated from 
the Diagnostic Radiology 
Residency Program, Brooke 
Army Hospital, San Antonio, 
Tex., in 1980. He was selected 
for promotion to Colonel in 
1981 and was appointed chief, 
department of radiology and 
nuclear medicine at Reynolds 
Army Hospital, Ft. Sill, Okla. 
Jan. 1, 1981. He spends his 
time flying, mountain climbing 
and jade carving. His daughter 
Wendy is a third-year medical 
student at Mayo Medical 
School and his son Kevin is a 
graduate student in 
math/computer science at the 
University of Texas. 
R. Michael Blaese, '64, chief, 
cellular immunology section, 
metabolism branch, National 
Cancer Institute, National 
Institutes of Health, received an 
E. Mead Johnson Award on 
Oct. 27 at the Academy 
meeting. He was honored for 
his work on immunodeficiency 
diseases, monocyte function 
and immune regulation and its 
disorders. He trained as a 
resident in the U of M's 
pediatrics department 1965-66. 
Other Minnesota trainees have 
received this award including 
Drs. Robert A. Good, Richard 
Smith, James G. White and 
Paul Quie. 
8/aese 
Richard A. Wright, '69, is 
director of adult medical 
services at the Denver 
Neighborhood Health program, 
Denver, Colo. He is an internist 
with a specialty in infectious 
diseases. His hobbies include 
skiing, marathon running, and 
high peak climbing. He and his 
wife Helen have two children, 
Jason and Michelle. 
1970s 
Jack Muellner, '72, is a family 
practice physician in charge at 
the San Bernadino Kaiser clinic 
in California. He writes that 
Southern California could use a 
few more "good family 
practitioners." 
Ronald R. Richardson, '73, has 
been appointed a consultant in 
the division of medical 
oncology at Mayo Clinic, 
working with Dr. D. L. Ahmann 
and Associates. He has been 
serving as assistant professor 
of medicine in the division of 
oncology at Vanderbilt 
University and chief of the 
division of oncology at St. 
Thomas Hospital, Nashville. 
John M. Mahowald, '77, 
completed a residency in 
internal medicine and plans to 
study pathology under the 
direction of Dr. Jesse Edwards. 
Afterwards, he will begin a 
cardiology fellowship in July, 
1981. While in Medical School 
here, he was a winner of a 
Minnesota Medical Foundation 
Student Research Grant. As a 
student in the U of M Graduate 
School, microbiology 
department, he conducted a 
six-month research project on 
the regulatory function of 




Robert Hugh Monahan, '42, a 
renown ophthalmologist, died 
of cancer at the age of 66, at 
the St. Paul Ramsey Hospital. 
He led the development of 
national standards for eye 
technicians and was chief of 
the St. Paul-Ramsey Medical 
Center Ophthalmology 
Department for 14 years. He 
also headed the U of M Medical 
School Eye Pathology 
Laboratory for 20 years and 
was in private practice in St. 
Paul as well. He founded and 
headed the Joint Commission 
on Allied Health Personnel in 
Ophthalmology, which sets 
national standards for 
paramedical personnel in eye 
care. He also served as 
president of the Minnesota 
Society for the Prevention of 
Blindness and the Minnesota 
Medical Alumni Society. 
Daniel R. Goldish, '32, a family 
practice physician in Duluth, 
Minn., died of cancer Oct. 25, 
1980, at the age of 72. Born in 
Duluth, he returned to Duluth 
after medical school to do 
family practice and surgery. He 
was in private practice until 
1978. He served as chief of staff 
of St. Mary's Hospital and was 
past president of the Duluth 
Symphony Association. Active 
in civic and religious affairs, he 
received a letter in 1969 from 
Israeli Defense Minister Moshe 
Dayan complimenting him on 
his efforts in behalf of Israel 
when he served as president of 
the Jewish Foundation. 
Gilbert Paul Wenzel, '37, died 
Nov. 1, at the age of 68 in 
Tarpon Springs, Fla., where he 
had lived after he retired. He 
had been one of the first family 
practice physicians in St. Paul. 
Born in St. Paul, he lived there 
until his.retirement. 
A family practice physician, 
he was a pioneer in group 
practice. He founded the Rice 
Street Clinic and the Capitol 
24 
City State Bank. A sportsman, 
he was a member of the 
gymnast team in the 1932 
Summer Olympics in Los 
Angeles. 
Leo L. Zachman, '30, a St. Paul 
family practice physician and 
general surgeon, died March 
25, 1980 at the age of 77- two 
years after his retirement from 
medical practice. Of German 
descent, he was conversant in 
German and treated many 
German patients. He did family 
practice and general surgery 
for 43 years. In the Army, he 
was chief surgeon in charge of 
the U.S. prisoners-of-war. 
Edward C. Menefee, '46, died 
in September, 1980 at St. 
Mary's Hospital in Rochester, 
Minn. He had been the 
Freeborn county coroner for 
the past 22 years. He was 56. A 
pathologist, he had practiced in 
Austin, Blue Earth, Owatonna, 
Wells and Albert Lea, Minn., 
and was affiliated for the past 
five years with the Laboratory 
of Clinical Medicine in Sioux 
Falls, S.D. 
Bernard E. O'Reilley, a 
postgraduate fellow in 
ophthalmology and 
otolaryngology at the U of M in 
1925, died July 8, 1980. He was 
79. After practicing several 
years in Minot, N.D., he 
returned to practice in St. Paul, 
where he was born. He was on 
the staffs of Miller, St. 
Joseph's, Children's and 
Ancker Hospitals. He retired 
from practice in 1959 and 
moved to Arizona. 
Schuyler P. Brown, '41, an 
orthopedic surgeon, died of 
cancer Dec. 1, 1980. He was 7 4. 
He had been an orthopedic 
surgeon at the Bay Pines VA 
Medical Center, Fla. 
Ralph F. Meincke, '50, a 
surgeon in Coos Bay, Ore., died 
of a coronary at the age of 61 in 
May, 1980. He had practiced 
there for the past 29 years. 
Born in Lake City, Minn., he 
was a veteran of World War II, 
serving as a Navy pilot. He held 
a naval reserve rank of captain. 
Duncan V. Luth, '41, an 
anesthesiologist from Spokane, 
Wash., died July, 1980. 
Fred C. Holzapfel, '36, a family 
practice physician from 
Minneapolis, Minn., died 
recently at the age of 71. He 
was retired and living in Golden 
Valley, Minn. 
Benjamin C. Sloan, '41, an 
internist from Los Angeles, 
died in March, 1979. 
Clarence H. Buckley, '33, a 
retired surgeon and family 
practice physician living in Eau 
Claire, Wis., died in March 
1980. 
Cecile P. Bell, 94, wife of the 
late Dr. Elexious T. ("Tommy") 
Bell, died in January. Dr. Bell 
was head of the University's 
department of pathology for 
more than 30 years. 
The family has requested that 
memorials for Mrs. Bell and Dr. 
Bell be given to the E. T. Bell 
Institute at the University, % 
the Minnesota Medical 
Foundation. Donors may use 
the envelope in the center of 
this magazine to send a 
memorial gift. Please indicate 
that your gift is a Bell 
memorial. 
We regret that we cannot 
provide more detailed 
information in some of our 
death notices, but oftentimes 
more information is not 
available to us within our 
deadline constraints. Rather 
than omit the notice or delay its 
announcement, our policy is to 
publish it so that our readers 
may be kept informed of 
friends' or colleagues' deaths. 
If further information becomes 
available, we will try to include 
it in a subsequent issue of the 
magazine. 
YES, to your family who will be 
better off financially and 
emotionally at your death if 
you leave a Will. 
YES, to friends or relatives you 
want to remember in a 
special way. 
YES, to yourself. You have a right 
to decide what will become 
of your life's earnings. 
YES, to the medical students and 
researchers who depend on 
individuals like you for 




An Oportunity to Say YES 
If you are interested in receiving 
additional information please print 
your name and address below and 
insert this card in the reply 
envelope in the center of this 
bulletin, or mail to: 
Donald A. Engel 
Minnesota Medical Foundation 
5412 Powell Hall 
University of Minnesota 
Minneapolis, MN 55455 
r------------------------------
Dear Mr. Engel: 
D Please send me your free booklet on wills. 
D Please send information about how to include the Minnesota 
Medical Foundation in my will. 
D I have already included MMF in my will. 
D Please check this box if you are a University of Minnesota Medical School graduate. 
Name ____________________________________________________ ___ 
Street Address ______________________ _ 
City __________________ .State _____ Zip ___ _ 
Minnesota Medical Foundation 
5412 Powell Hall University of Minnesota 
Minneapolis, Minn. 55455 
Minnesota Medical Foundation 
5412 Powell Hall University of Minnesota 
Minneapolis, Minn. 55455 
Phone: (612) 373-8023 
ADDRESS CORRECTION REQUESTED 
Happy New Year from the Minnesota Medical Foundation. 
UNIVERSITY ARCHIVES 
10 WALTER LIBRARY 
UNIV OF MINNESOTA 
MINNEAPOLIS, MN 55455 
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